litlas
ログインアカウント作成

Xiaohua Wu

1993–2026 年に発表

377
論文数
30,892
被引用数
91
h 指数
282
i10 指数

被引用数

Xiaohua Wu の年別被引用数1992 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 23 件1995 年: 被引用 26 件1996 年: 被引用 36 件1997 年: 被引用 36 件1998 年: 被引用 27 件1999 年: 被引用 34 件2000 年: 被引用 83 件2001 年: 被引用 104 件2002 年: 被引用 117 件2003 年: 被引用 100 件2004 年: 被引用 133 件2005 年: 被引用 110 件2006 年: 被引用 110 件2007 年: 被引用 90 件2008 年: 被引用 102 件2009 年: 被引用 159 件2010 年: 被引用 154 件2011 年: 被引用 109 件2012 年: 被引用 145 件2013 年: 被引用 156 件2014 年: 被引用 171 件2015 年: 被引用 161 件2016 年: 被引用 149 件2017 年: 被引用 165 件2018 年: 被引用 232 件2019 年: 被引用 708 件2020 年: 被引用 935 件2021 年: 被引用 1,009 件2022 年: 被引用 875 件2023 年: 被引用 769 件2024 年: 被引用 1,403 件2025 年: 被引用 874 件2026 年: 被引用 76 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,020 件、この内訳の 23.4%中国: 引用元論文 2,835 件、この内訳の 22%イギリス: 引用元論文 725 件、この内訳の 5.6%ドイツ: 引用元論文 447 件、この内訳の 3.5%イタリア: 引用元論文 394 件、この内訳の 3.1%日本: 引用元論文 376 件、この内訳の 2.9%カナダ: 引用元論文 359 件、この内訳の 2.8%フランス: 引用元論文 343 件、この内訳の 2.7%インド: 引用元論文 281 件、この内訳の 2.2%スペイン: 引用元論文 277 件、この内訳の 2.1%オーストラリア: 引用元論文 275 件、この内訳の 2.1%韓国: 引用元論文 275 件、この内訳の 2.1%
0%23.4%その他 25.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology44%
  • Medicine27.9%
  • Computer Science7.1%
  • Engineering6.9%
  • Immunology and Microbiology3.9%
  • Neuroscience2.8%
  • その他7.4%

トピック

  • DNA Repair Mechanisms5.5%
  • Computational Drug Discovery Methods2.3%
  • CRISPR and Genetic Engineering2.3%
  • Cancer-related molecular mechanisms research1.9%
  • PARP inhibition in cancer therapy1.8%
  • Bioinformatics and Genomic Networks1.7%
  • その他84.5%

共著者

全論文

検索で開く
  1. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

    著者: Aravind Subramanian, Rajiv Narayan, Steven M. Corsello, D. D. Peck, Ted Natoli, Xiaodong Lü, Joshua Gould, John F. Davis, Andrew A. Tubelli, Jacob K. Asiedu, David L. Lahr, Jodi Hirschman, Zihan Liu, Melanie Donahue, Bina Julian, Mariya Khan, David Wadden, Ian C. P. Smith, Daniel D. Lam, Arthur Liberzon, Courtney Toder, Mukta Bagul, Marek Orzechowski, Oana M. Enache, Federica Piccioni, Sarah Johnson, Nicholas Lyons, Alice H. Berger, Alykhan F. Shamji, Angela N. Brooks, Anita Vrcic, Corey Flynn, Jacqueline Rosains, David Y. Takeda, Roger Hu, Desiree Davison, Justin Lamb, Kristin Ardlie, Larson Hogstrom, Peyton Greenside, Nathanael S. Gray, Paul A. Clemons, Serena J. Silver, Xiaoyun Wu, Wen‐Ning Zhao, Willis Read-Button, Xiaohua Wu, Stephen J. Haggarty, Lucienne Ronco, Jesse S. Boehm, Stuart L. Schreiber, John G. Doench, Joshua A. Bittker, David E. Root, Bang Wong, Todd R. Golub - Cell 2017 被引用: 3,788

  2. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

    著者: Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon, Jung‐Yun Lee, Jessica Thomes Pepin, Michael Sundborg, Ayelet Shai, Joseph de la Garza, Shin Nishio, Michael A. Gold, Ke Wang, Kristi McIntyre, Todd Tillmanns, Stephanie V. Blank, Jihong Liu, Michael McCollum, Fernando Contreras Mejía, Tadaaki Nishikawa, Kathryn P. Pennington, Zoltan Novak, Andréia Cristina de Melo, Jalid Sehouli, Dagmara Klasa-Mazurkiewicz, Christos Papadimitriou, Marta Gil-Martín, Birute Brasiuniene, Conor Donnelly, Paula Michelle del Rosario, Xiaochun Liu, Els Van Nieuwenhuysen, Sophia Frentzas, Ganessan Kichendasse, Bo Gao, Tarek Meniawy, Linda Mileshkin, Gary Richardson, Felicia Roncolato, Jean‐François Baurain, Maryam Bourhaba, Eveline Cuypere, Philip R. Debruyne, Hannelore Denys, Frédéric Forget, Brigitte Honhon, E. Joosens, Els Van Nieuwenhuysen, Vanessa da Costa Miranda, Andréia Cristina de Melo, Joao Daniel Guedes, Charles Andreé Joseph de Pádua, Nicolas Lazaretti, Carolina Martins Vieira, André Mattar, Daniela Neves Palmeiro, Christina Pimentel Oppermann Kussler, Pedro Emanuel Rubini Liedke, João Soares Nunes, Katsuki Arima Tiscoski, Allan Covens, Lara De Guerké, Prafull Ghatage, Lucy Gilbert, Susie Lau, Amit M. Oza, Diane Provencher, Omar Touhami, Congzhu Li, Danbo Wang, Ge Lou, Zhu Genhai, Guiling Li, Shi Hong, Hong Zheng, Wen Hongwu, Jihong Liu, Jing Wang, Ke Wang, Jiang Kui, Li Li, Wang Li, Hao Min, Qi Zhou, Gao Qinglei, Sihai Liao, Zhang Songling, Zhao Weidong, Xiaohua Wu, Wuliang Wang, Rutie Yin, Cheng Ying, Yu Zhang, Liang Zhiqing, Fernando Contreras Mejía, Ángel Luis Martín de Francisco Hernández, Carolina Ortiz Lopez, Carlos Javier Pacheco, Pedro Luis Ramos Guette, Jaime Rendon Pereira, Julian Rivera Diaz, Tomás Sánchez Villegas ほか 156 名 - Journal of Clinical Oncology 2023 被引用: 331

  3. Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

    著者: Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Çağatay Taşkıran, Katina Robison, Johanna Mäenpää, Lyndsay Willmott, Nicoletta Colombo, Jessica Thomes-Pepin, Michalis Liontos, Michael A. Gold, Yolanda García García, Sudarshan Sharma, Christopher J. Darus, Carol Aghajanian, Aikou Okamoto, Xiaohua Wu, Р. С. Сафин, Fan Wu, Luciana Molinero, Vidya Maiya, Victor K. Khor, Yvonne G. Lin, Sandro Pignata - Journal of Clinical Oncology 2021 被引用: 406

  4. Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

    著者: Xiangyu Gao, Nong Xu, Ziyu Li, Lin Shen, Ke Ji, Zhong Zheng, Dan Liu, Hanmei Lou, Li Bai, Tianshu Liu, Yunxia Li, Yuzhi Li, Qingxia Fan, Feng Mei, Haijun Zhong, Yi Huang, Ge Lou, Jing Wang, Xiaoyan Lin, Ye Chen, Ruifang An, Changzheng Li, Qi Zhou, Xin Huang, Zengqing Guo, Shubin Wang, Guiling Li, Junwei Fei, Lijing Zhu, Hong Zhu, Xiu-Min Li, Fenghu Li, Sihai Liao, Qinghua Min, Lei Tang, Fei Shan, Jifang Gong, Yunong Gao, Jun Zhou, Zhihao Lü, Xiaofan Li, Jianjie Li, Hui Ren, Xiaohong Liu, Hongxia Yang, Wenting Li, Weifeng Song, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Xiaohua Wu, Jiafu Ji - The Lancet Oncology 2023 被引用: 197

  5. Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

    著者: Bradley J. Monk, Takafumi Toita, Xiaohua Wu, Juan Carlos Vázquez Limón, R. Tarnawski, Masaki Mandai, Ronnie Shapira‐Frommer, Umesh Mahantshetty, Maria Del Pilar Estevez-Diz, Qi Zhou, Sewanti Limaye, Francisco Javier Ramírez Godinez, Christina Oppermann Kussler, Szilvia Varga, Natalia Valdiviezo, Daisuke Aoki, Manuel Leiva, Jung‐Yun Lee, Raymond Sulay, Yulia Kreynina, Wen‐Fang Cheng, Felipe Rey, Yi Rong, Guihao Ke, Sophie Wildsmith, Andrew R. Lloyd, Hannah Dry, Ana T. Nunes, Jyoti Mayadev - The Lancet Oncology 2023 被引用: 204

  6. Learning to Routing in UAV Swarm Network: A Multi-Agent Reinforcement Learning Approach

    著者: Zunliang Wang, Haipeng Yao, Tianle Mai, Zehui Xiong, Xiaohua Wu, Di Wu, Song Guo - IEEE Transactions on Vehicular Technology, IEEE Trans. Veh. Technol. 2022 被引用: 76

  7. Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer

    著者: Ning Li, Jianqing Zhu, Rutie Yin, Jing Wang, Lingya Pan, Beihua Kong, Hong Zheng, Jihong Liu, Xiaohua Wu, Li Wang, Yi Huang, Ke Wang, Dongling Zou, Hongqin Zhao, Chunyan Wang, Weiguo Lü, Lin An, Ge Lou, Guiling Li, Pengpeng Qu, Hongying Yang, Yu Zhang, Hongbing Cai, Yueyin Pan, Min Hao, Ziling Liu, Heng Cui, Yingjie Yang, Shuzhong Yao, Xiaoa Zhen, Wenzhao Hang, Jianmei Hou, Juan Wang, Lingying Wu - JAMA Oncology 2023 被引用: 159

  8. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease

    著者: Licong Yang, Yabin Wang, Zhiwei Li, Xiaohua Wu, Jingtao Mei, Guodong Zheng - Carbohydrate Polymers 2023 被引用: 97

  9. Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells

    著者: Lan N. Truong, Yongjiang Li, Linda Shi, Patty Yi-Hwa Hwang, Jing He, Hailong Wang, N. Razavian, Michael W. Berns, Xiaohua Wu - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 被引用: 516

  10. Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials

    著者: Bradley J. Monk, Takayuki Enomoto, W. Martin Kast, Mary McCormack, David S.P. Tan, Xiaohua Wu, Antonio González-Martı́n - Cancer Treatment Reviews 2022 被引用: 130

  11. Global prevalence of turnover intention among intensive care nurses: A meta‐analysis

    著者: Guoilian Xu, Xiaoying Zeng, Xiaohua Wu - Nursing in Critical Care 2021 被引用: 156

  12. Advances in diagnosis and treatment of metastatic cervical cancer

    著者: Haoran Li, Xiaohua Wu, Xi Cheng - Journal of Gynecologic Oncology 2016 被引用: 531

  13. Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

    著者: Xiaohua Wu, Jianqing Zhu, Rutie Yin, Jiaqian Yang, Jihong Liu, Junke Wang, Lingying Wu, Z.L. Liu, Yunong Gao, Dongsheng Wang, Ge Lou, Haizhen Yang, Qi Zhou, Beihua Kong, Yi Huang, L.P. Chen, Guangyao Li, Rui An, K. Wang, Yu Zhang, Xiaojian Yan, Xin Lu, Weiguo Lü, Min Hao, Lai Wang, Heng Cui, Qingmei Chen, Guzhalinuer Abulizi, Xianghua Huang, Xusheng Tian, Hao Wen, C. Zhang, Jianmei Hou, Mansoor Raza Mirza - Annals of Oncology 2021 被引用: 206

  14. FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2

    著者: Fei Xu, Jiajia Li, Mengdong Ni, Jingyi Cheng, Haiyun Zhao, Shanshan Wang, Xiang Zhou, Xiaohua Wu - Molecular Cancer 2021 被引用: 139

  15. PIF1 helicase promotes break‐induced replication in mammalian cells

    著者: Shibo Li, Hailong Wang, Sanaa E. Jehi, Jun Li, Shuo Liu, Zi Wang, Lan N. Truong, Takuya Chiba, Zefeng Wang, Xiaohua Wu - The EMBO Journal 2021 被引用: 104

  16. Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)

    著者: Xiaohua Wu, Jiafu Ji, Hanmei Lou, Yunxia Li, Mei Feng, Nong Xu, Yuzhi Li, Jing Wang, Yi Huang, Ge Lou, Ruifang An, Changzheng Li, Qi Zhou, Xin Huang, Enfeng Zhao, Tianshu Liu, Qingxia Fan, Guiling Li, Baiyong Li, Yu Xia - Gynecologic Oncology 2022 被引用: 62

  17. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway

    著者: Shaojia Wang, Jiajia Li, Jie Xie, Fei Liu, Yachen Duan, Yong Wu, Shenglin Huang, Xianghuo He, Ziliang Wang, Xiaohua Wu - Oncogene 2018 被引用: 126

  18. Excitatory SST neurons in the medial paralemniscal nucleus control repetitive self-grooming and encode reward

    著者: Jingjing Sun, Yuan Yuan, Xiaohua Wu, Anqi Liu, Jingjie Wang, Shuo Yang, Bing Liu, Yalei Kong, Lizhao Wang, Kai Zhang, Qian Li, Siyu Zhang, Tifei Yuan, Tian‐Le Xu, Ju Huang - Neuron 2022 被引用: 52

  19. Direct Septum-Hippocampus Cholinergic Circuit Attenuates Seizure Through Driving Somatostatin Inhibition

    著者: Ying Wang, Ying Wang, Yi Wang, Yi Wang, Cenglin Xu, Shuang Wang, Na Tan, Cong Chen, Liying Chen, Xiaohua Wu, Fan Fei, Heming Cheng, Wenkai Lin, Yingbei Qi, Bin Chen, Jiao Liang, Junli Zhao, Zhenghao Xu, Yi Guo, Shihong Zhang, Xiao‐Ming Li, Yudong Zhou, Shumin Duan, Zhong Chen - Biological Psychiatry 2019 被引用: 97

  20. Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN Is Important for DNA Double-strand Break Repair

    著者: Longchuan Chen, Christian J. Nievera, Alan Yueh‐Luen Lee, Xiaohua Wu - Journal of Biological Chemistry 2008 被引用: 408

  21. The Interaction of CtIP and Nbs1 Connects CDK and ATM to Regulate HR–Mediated Double-Strand Break Repair

    著者: Hailong Wang, Linda Shi, Catherine C. L. Wong, Xuemei Han, Patty Yi-Hwa Hwang, Lan N. Truong, Qingyuan Zhu, Zhengping Shao, David J. Chen, Michael W. Berns, John R. Yates, Longchuan Chen, Xiaohua Wu - PLoS Genetics 2013 被引用: 257

  22. Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

    著者: Xiaohua Wu, Yang Sun, Hongying Yang, Jing Wang, Hanmei Lou, Dan Li, Xiuli Wang, Hui Zhang, Tao Wu, Y. Li, Chunyan Wang, Guiling Li, Yifeng Wang, Dapeng Li, Ying Tang, Mei Pan, Hongyi Cai, Weihu Wang, Bing Yang, Hua Qian, Qiu‐Hong Tian, Desheng Yao, Ying Cheng, Bing Wei, Xiu-Min Li, Tao Wang, Min Hao, Xiaohong Wang, Tiejun Wang, Juntao Ran, Hong Zhu, Lijing Zhu, Xianling Liu, Yunxia Li, Lihong Chen, Qingshan Li, Xiaojian Yan, Fei Wang, Hongbing Cai, Yunyan Zhang, Zhiqing Liang, Funan Liu, Yi Huang, Bairong Xia, Pengpeng Qu, Zhu Genhai, Youguo Chen, Kun Song, Meili Sun, Zhengzheng Chen, Qiang Zhou, Lina Hu, Guzhalinuer Abulizi, Hongyan Guo, Sihai Liao, Yijing Ye, Ping Yan, Tang Qiu, Guoping Sun, Ting Liu, Dongmei Lu, Mingxiu Hu, Zhongmin M Wang, Baiyong Li, Michelle Xia - The Lancet 2024 被引用: 102

  23. Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

    著者: Ning Li, Youzhong Zhang, Jing Wang, Jianqing Zhu, Li Wang, Xiaohua Wu, Desheng Yao, Qiang Wu, Jihong Liu, Junying Tang, Rutie Yin, Ge Lou, Ruifang An, Guonan Zhang, Xiaoping Xia, Qingshui Li, Yaping Zhu, Hong Zheng, Xinfeng Yang, Yuanjing Hu, Xin Zhang, Min Hao, Yi Huang, Zhongqiu Lin, Dong Wang, Xiaoqing Guo, Shuzhong Yao, Xiaoyun Wan, Huaijun Zhou, Liangqing Yao, Xielan Yang, Heng Cui, Yuanguang Meng, Songling Zhang, Jing Qu, Ben Zhang, Jianjun Zou, Lingying Wu - Journal of Clinical Oncology 2022 被引用: 73

  24. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

    著者: Min Yu, Mengdong Ni, Fei Xu, Chaohua Liu, Lihua Chen, Jiana Li, Siyu Xia, Yixin Diao, Jiaxin Chen, Jun Zhu, Xiaohua Wu, Min Tang, Jiajia Li, Guihao Ke - Molecular Cancer 2024 被引用: 48